Skip to main content
Clinical Trials/JPRN-UMIN000002659
JPRN-UMIN000002659
Completed
Phase 2

Evaluation of effects of enteral nutrient enriched with eicosapentaenoic acid (EPA), gamma-linolenic acid (GLA), and antioxidants in patients underwent radical surgery for thoracic esophageal cancer. - Evaluation of effects of enteral nutrient enriched with eicosapentaenoic acid (EPA), gamma-linolenic acid (GLA), and antioxidants in patients underwent radical surgery for thoracic esophageal cancer.

Osaka City University Hospital, Second Department of Surgery0 sites80 target enrollmentNovember 1, 2009

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Esophageal cancer
Sponsor
Osaka City University Hospital, Second Department of Surgery
Enrollment
80
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 1, 2009
End Date
October 1, 2012
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Osaka City University Hospital, Second Department of Surgery

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Palliative and Emergency esophagectomy case Patients with severe immunosuppression Patients with cardiac, liver, or renal failure Patients with abnormal amino acid metabolism Known allergy of milk protein and lactose intolerance Patients assessed to be unsuitable for inclusion the study or enteral feeding

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Effect of an enteral diet enriched with gamma linolenic acid, eicosapentaenoic acid and antioxidants upon the course of critically ill patients with sepsisSystemic inflammatory response syndrome (SIRS)Infections and InfestationsOther septicaemia
ISRCTN67182335Spanish Society of Intensive Care (Sociedad Española de Medicina Intensiva) (Spain)272
Recruiting
Phase 3
The effect of enteral feeding on weaning of mechanical ventilation patientsPatients under mechanical ventilation.Mechanical complication of ventricular intracranial (communicating) shunt
IRCT20171221037983N3Oroumia University of Medical Sciences100
Not yet recruiting
Not Applicable
Study for efficacy of usage of enteral nutrient with immuno-balance modulation action in perioperative management of pediatric patientsHirschsprung&#39s disease, Atresia ani, Congenital biliary dilatation, GERD
JPRN-UMIN000024993niversity of Tsukuba Hospital10
Not yet recruiting
Phase 2
Oncoxin®-Viusid®- Quality of life of patients with metastatic colorectal adenocarcinoma-adults-Phase IIMetastatic colorectal adenocarcinomaColorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsRectal DiseasesColonic DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System Diseases
RPCEC00000276Catalysis S40
Not yet recruiting
Phase 2
Oncoxin-Viusid / Pancreatic adenocarcinoma / Adults / Phase IIPancreatic cancerPancreatic NeoplasmsDigestive System NeoplasmsEndocrine Gland NeoplasmsPancreatic DiseasesDigestive System DiseasesEndocrine System Diseases
RPCEC00000281aboratories Catalysis, S.A30